Photodynamic efficacy of hypericin targeted by two delivery techniques to hepatocellular carcinoma cells

被引:12
作者
Fadel, Maha [2 ]
Kassab, Kawser [3 ]
Youssef, Tareq [1 ]
机构
[1] Cairo Univ, Photobiosci Lab, Div Photochem & Photobiol, NILES, Giza 12613, Egypt
[2] Cairo Univ, Pharmaceut Technol Lab, Med Laser Applicat Dept, NILES, Giza 12613, Egypt
[3] Cairo Univ, Cell Photosensitizat Lab, Med Laser Applicat Dept, NILES, Giza 12613, Egypt
关键词
Photodynamic therapy; Hypericin; Drug carrier; Anti-hepatocyte specific antigen; Liposomes; Hepatocellular carcinoma; ANTIVIRAL AGENT HYPERICIN; IN-VITRO; HUMAN GLIOBLASTOMA; SINGLET OXYGEN; THERAPY; FLUORESCENCE; CANCER; PHOTOSENSITIZATION; PHOTOIMMUNOTHERAPY; LOCALIZATION;
D O I
10.1007/s10103-010-0787-8
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The photocytotoxic effect of hypericin (Hyp) targeted by two different delivery techniques, namely, liposomes and anti-hepatocyte specific antigen (anti-HSA) was investigated. Optical absorption and steady-state fluorescence were used to analyze the conjugation of Hyp with anti-HSA model and to evaluate the encapsulation capacity and drug release in a liposome model. Particle size and thermal analysis of the prepared liposomes were performed using laser-light scattering and differential scanning calorimetry (DSC), respectively. Viability study of HepG2 cells exposed to Hyp in the two delivery systems, in the dark and following visible light irradiation, was performed in comparison to free Hyp. The intracellular uptake and localization of Hyp in HepG2 cells were analyzed by means of spectrofluorometry and fluorescence microscopy. Spectroscopic measurements demonstrated that Hyp binds to anti-HSA in its monomeric form. The photocytotoxic effect of Hyp depended clearly on the form of Hyp administered, either in free form, loaded into liposomes or conjugated with anti-HSA. While liposomes loaded with Hyp (Lip-Hyp) did not induce significant phototoxicity, both free Hyp or anti-HSA-Hyp inflicted substantial cell mortality, after photoirradiation. The intracellular uptake of Lip-Hyp by HepG2 cells was estimated to be 20% less compared to free Hyp or anti-HSA-Hyp. In spite of the equal uptake of both free Hyp and anti-HSA-Hyp, HepG2 cells demonstrated a relatively higher mortality with anti-HSA-Hyp compared to free Hyp.
引用
收藏
页码:675 / 683
页数:9
相关论文
共 50 条
  • [31] N-acetylgalactosamine-decorated nanoliposomes for targeted delivery of paclitaxel to hepatocellular carcinoma
    Li, Tingshen
    Yu, Peng
    Chen, Yihao
    Sun, Baoying
    Dong, Peijie
    Zhu, Tao
    Meng, Xin
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 222
  • [32] Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma
    Shehata, Eman M. M.
    Gowayed, Mennatallah A.
    El-Ganainy, Samar O.
    Sheta, Eman
    Elnaggar, Yosra S. R.
    Abdallah, Ossama Y.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 619
  • [33] ULTRASOUND-TARGETED MICROBUBBLE DESTRUCTION ENHANCES THE ANTITUMOR EFFICACY OF DOXORUBICIN IN A MOUSE HEPATOCELLULAR CARCINOMA MODEL
    Wu, Ying
    Sun, Ting
    Tang, Jinhua
    Liu, Yang
    Li, Fenghua
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2020, 46 (03) : 679 - 689
  • [34] Recent advances in optimizing siRNA delivery to hepatocellular carcinoma cells
    Weiskirchen, Ralf
    Weiskirchen, Sabine
    Grassi, Chiara
    Scaggiante, Bruna
    Grassi, Mario
    Tierno, Domenico
    Biasin, Alice
    Truong, Nhung Hai
    Minh, Thanh Dang
    Cemazar, Maja
    Pastorin, Giorgia
    Tonon, Federica
    Grassi, Gabriele
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2025, : 729 - 745
  • [35] Engineered nanoparticles for imaging and targeted drug delivery in hepatocellular carcinoma
    Xianzhe Yu
    Qin Zhang
    Leibo Wang
    Yan Zhang
    Lingling Zhu
    [J]. Experimental Hematology & Oncology, 14 (1)
  • [36] Preparation and evaluation of targeted albumin lipid nanoparticles with lactobionic acid for targeted drug delivery of sorafenib in hepatocellular carcinoma
    Dayani, Ladan
    Dehghani, Mahla
    Aghaei, Mahmoud
    Taymouri, Somayeh
    Taheri, Azade
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 69
  • [37] Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
    Nair, Anroop B.
    Shah, Jigar
    Al-Dhubiab, Bandar E.
    Patel, Snehal S.
    Morsy, Mohamed A.
    Patel, Vimal
    Chavda, Vishal
    Jacob, Shery
    Sreeharsha, Nagaraja
    Shinu, Pottathil
    Attimarad, Mahesh
    Venugopala, Katharigatta N.
    [J]. MOLECULES, 2019, 24 (24):
  • [38] Exosomes as a window of opportunity in hepatocellular carcinoma: Insights from diagnostic to targeted drug delivery
    Gupta, S.
    Deb, A.
    Mazumder, P. B.
    Shekhawat, G. S.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 101
  • [39] Hyaluronic acid-modified extracellular vesicles for targeted doxorubicin delivery in hepatocellular carcinoma
    Liu, Yue
    Hinnant, Benjamin
    Chen, Shang
    Tao, Hongyan
    Huang, Ziyu
    Qian, Meng
    Zhou, Manqian
    Han, Zhibo
    Han, Zhong-Chao
    Zhang, Jun
    Li, Zongjin
    [J]. EXPERIMENTAL CELL RESEARCH, 2024, 443 (02)
  • [40] Glycyrrhizin Acid and Glycyrrhetinic Acid Modified Polyethyleneimine for Targeted DNA Delivery to Hepatocellular Carcinoma
    Cao, Mingzhuo
    Gao, Yong
    Zhan, Mengling
    Qiu, Nasha
    Piao, Ying
    Zhou, Zhuxian
    Shen, Youqing
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)